chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Her Pfizer booster shot was yesterday; Her Pfizer booster shot was yesterday; felt very tired; wasn't able to sleep good; body aches; woke up with sore arm; diarrhea; vomiting; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported for herself. A 75-year-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 3 via an unspecified route of administration on 28Sep2021 10:30 (at the age of 75-year-old) (Batch/Lot number was not reported) as dose 3 (booster), single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient previously took first and second dose of BNT162B2 on an unspecified date for covid-19 immunisation and experienced sore arm in both doses. Patient previously took flu shot and she just got really sick, diarrhoea and vomiting but not same time, after some time got butter just colds sweat. She also added that it also happened years ago with her mom. The patient had her Pfizer booster shot 3 on 28Sep2021 at 10:30, which was an extra dose and was exposed to an off-label scenario, and experienced body aches, diarrhoea, vomiting, felt very tired, wasn't able to sleep good and woke up with sore arm. Also stated she was unsure if maybe the side effects were really because of the booster shot or maybe there is something in your system beforehand, she would just talk to her doctor. The outcome felt very tired, wasn't able to sleep good, body aches, woke up with sore arm, diarrhea and vomiting was not recovered. The outcome of all the other events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
pt recvd vax; screaming, grabbing but missing thinks, looking at mom but looking past her in the wrong direction, and stiffening; not a sz; was fussy a few hrs after vax; lasted approx 20 hrs; no tx required;
Patient received an adult Pfizer booster vaccine in the left arm(Lot# FF88411, Expiration Date 01/03/22).  While in the Observation Area client reported blurry vision and feeling light headed at approximately 1034.  At that time patient also self administered own medications of Lorazepam and Tylenol as prescribed for symptoms she was experiencing.  PHN's present in Observation Area.  Patient was assisted to the anti-gravity chair, Blood Pressure 142/86, SaO2 98% on room air, Pulse 92, breathing unlabored, alert and oriented to person, place, time, and situation.  Patient states, "blurry vision is getting better, a little."  Patient denied reactions to COVID vaccine 1st and 2nd doses.  1040:  Blood Pressure 142/88, SaO2 98% on room air, Pulse 82, breathing unlabored, no changes in mentation.  Patient denies dizziness, admits to eating coffee and toast at approximately 0800.  1052: Blood Pressure 143/88, SaO2 99% on room air, Pulse 84, breathing unlabored, no changes in mentation.  Patient states she "feels dizzy with high blood pressure."  1054:  Patient states she "feels fine," PHN educates patient on signs and symptoms of anaphylaxis and to call 911 or go to nearest emergency department for any signs or symptoms, advises patient to follow up with primary care provider regarding blood pressure. Patient admits she has 2-3 episodes of dizziness daily and also has diabetes she no longer takes medication for.  1055:  Patient leaves with husband for home.
Diarrhea; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL1283) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient experienced diarrhea on an unspecified date. It was reported Consumer stated, No, I had a shot and I have had diarrhea since I have had it and I was wondering do I need to take the other one or would it be best I do not take the other shot. Well, I was wanting to watch this program on TV. I had been waiting a long time. The reason why I called was to find out if I should have the other shot as I have had diarrhea. The outcome of the event was unknown. Follow-up attempts are completed. No further information is expected.
Redness, pain, burning of oral cavity and throat beginning on day after injection of FLUZONE HIGH DOSE.
Information has been received from a physician concerning a 4-year-old female who, in approximately 2002, around her first birthday, was vaccinated with a dose of varicella virus vaccine live.  On 06-DEC-2005, the patient developed breakthrough, noted to be 12 to 15 lesions.  The child was out of school for 2 weeks but it was unknown what the outcome was.  Unspecified medical attention was sought.  The outcome was reported as recovered.  There was no product quality complaint.  Additional information has been requested.
Warm; itching; swelling; redness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Warm), VACCINATION SITE PRURITUS (itching), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE ERYTHEMA (redness) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm), VACCINATION SITE PRURITUS (itching), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE ERYTHEMA (redness). At the time of the report, VACCINATION SITE WARMTH (Warm), VACCINATION SITE PRURITUS (itching), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE ERYTHEMA (redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not provided.
Pt presented for second vaccine and stated after his first vaccine he experienced severe chest tightness. He was watched by the EMS but the symptoms never progressed. Prior to receiving his second dose the patient was given 50 mg Benadryl, waiting 15 minutes and then given his vaccine. The patient felt well and did not experience any symptoms. The patients wife was the driver.
I don't know if any of his adverse events are related I wanted the CDC to be aware. He started feeling uneasy, unwell, vomiting, itchy ears (both), upper chest pain, upper back pain and difficulty breathing. We went to the ER at 17:00 - 22:00 on 7/18 was discharged couldn't figure out what was happening was given medication for migraine, Benadryl, Loratadine.
Breast inflammation near nipple next morning for 2 days. Only on side of body where flu shot was given. Redness and slightly irritating.
Modern a COVID-19 Vaccine EUA - about 8 pm on day of injection started with chills, then fever 100.1, headache, nausea, fatigue, redness and swelling at injection site over course of 31 hours after vaccine, which was given at 10 am
a lot of pain, All over her body, saying she can feel every muscle and organ.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (a lot of pain, All over her body, saying she can feel every muscle and organ.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (a lot of pain, All over her body, saying she can feel every muscle and organ.). At the time of the report, PAIN (a lot of pain, All over her body, saying she can feel every muscle and organ.) outcome was unknown.            Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
No other adverse effects were reported in the patient; a patient received an improperly stored dose of PROQUAD; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not provided.   On 05-NOV-2019 the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (lot # S012472 with expiration date 20-OCT-2020; dose, frequency and route of administration were not reported) for prophylaxis. No other adverse effects were reported in the patient.   The temperature excursion was ranged from 6 Fahrenheit Degree to 14 Fahrenheit Degree (-14 Celsius Degree to -10 Celsius Degree) (7.9F) for 20 minutes. The previous temperature excursion was ranged from 6 Fahrenheit Degree to 14 Fahrenheit Degree (-14 Celsius Degree to -10 Celsius Degree) (8.2F) for 40 minutes. Data logger was involved.
pt recv vax 1DEC97 & pt was found to be pregnant by a urine pregnancy test;An ultrasound was performed on 3DEC97 which indicated the fetus was 8-12wk gestation;
It was reported that a 22 year old female had a 5cm to 5.5cm red, swollen, tender reaction at injection site, within 48 hours of the 2nd injection. It was reported that the pt recovered. From follow-up information received on 9/30/99, it was reported, "Reviewed, no additional information at this time".
pt presented w/pneumoccal meningitis 24OCT93 p/having received vax 21OCT93;
This spontaneous report has been received from a female consumer of unknown age referring to herself. Concurrent or historical condition was not provided. On an unspecified date of November 2015 the patient was vaccinated with a dose of GARDASIL (dose, route, lot number and expired date unknown). On an unspecified date of November 2015 the patient developed one pimple-like bump near the injection site. The outcome of the event was unknown. The causality was not provided. Additional information is not expected as no contact information was provided. Additional information is not expected as no contact information was provided.
23 minutes after the patient receive the shot she complained of tingling at the site and down her arm. Provided patient with 2 25mg Benadryl to self administer. Upon checking at 1pm and 7:00pm patient was feeling better.
some pain in the injection site arm; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (some pain in the injection site arm) and PYREXIA (low grade fever) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced INJECTION SITE PAIN (some pain in the injection site arm) and PYREXIA (low grade fever). On 05-Apr-2021, INJECTION SITE PAIN (some pain in the injection site arm) and PYREXIA (low grade fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. No treatment medication were provided.    This case was linked to MOD-2021-101818 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow up received on 28-Jul-2021 and contains no new information.
Maintained all the improvements with RA after first booster dose/Improvements in IL6 driven autoimmune disease after vaccination/Rheumatory Arthritis (RA) has gone away after 4 Moderna vaccination; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Maintained all the improvements with RA after first booster dose/Improvements in IL6 driven autoimmune disease after vaccination/Rheumatory Arthritis (RA) has gone away after 4 Moderna vaccination) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A, 033C21A, 007M20A and 030L20A) for COVID-19 vaccination.     Previously administered products included for RA: Methotrexate in 2018 and LEFLUNOMIDE until August 2020. Past adverse reactions to the above products included No adverse event with LEFLUNOMIDE and Methotrexate. Concurrent medical conditions included RA since 2014 and Cancer.   On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jan-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2022, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Maintained all the improvements with RA after first booster dose/Improvements in IL6 driven autoimmune disease after vaccination/Rheumatory Arthritis (RA) has gone away after 4 Moderna vaccination). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Maintained all the improvements with RA after first booster dose/Improvements in IL6 driven autoimmune disease after vaccination/Rheumatory Arthritis (RA) has gone away after 4 Moderna vaccination) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Rheumatological examination: normal (normal) zero positive RA.         No concomitant medication were reported. Patient stated that after vaccination all positive RA numbers went down. All RA manifestations went away. Lab test Predictors of RA are completely gone. The patient had minimal arthritis symptoms from time to time and it goes away without using any medications. No treatment information were provided.   This case was linked to MOD-2022-564583, MOD-2022-564650, MOD-2022-564648 (Patient Link).
. Patient described sores/blisters and tight skin all over neck, arms, and in hair. Patient states a lot of pain and discomfort interrupting sleep.  She has had increased migraines and flares in eczema (pre-existing conditions).     Patient's  states  skin looked like it has burns on it  around her  neck  and scaly  and  very irritated  from itching  and scratching
Local dermatitis 7 cm in diameter started evening after shot in same arm.    Treating with Benadryl, topical corticosteroids
papular non erythemic multiple raised lesions;non vesicular @ deltoid muscle bilat;parent denies fever, lethargy, no chang in appetite or visible scratching;+appetite/activity/sleep patterns. Doctor did not examine child during visit.
20 hr. after Tdap injection, (L) arm with 4" diameter area of redness, swelling, extreme tenderness, hot to touch but no systemic fever. Mother taking her to pediatrician - physician ordered SEPTRA Bid x 10 days. On 7/25/2011 was doing better, per mother.
Initial adverse reaction was pain in right arm and slight redness at injection site. This initial pain last approximately 2 days. 10 days later, and a few inches below the injection site, I developed a large red rash area. The rash area felt like a large knot under the skin and was initially about the size of a baseball. The rash area felt hot to the touch and itched. The next day, the rash area was larger, more spread out in the same general area and there was slightly less hardness under the skin.  This is the third day of the symptoms. Right arm between elbow and shoulder remain red and itchy.
Headache, Sedation, Myalgia, Arthralgia, Fever, CoughWheeze, congestion, red lesion on arm Narrative:  Other Relevant History:
Narrative:  72yo patient residing at nursing facility died on 9/21/21 at LTC facility. Daughter reported that after speaking to facility ANRP today about Hospice care, she received a 2nd call from ANRP informing her that her father had died in his sleep at facility. Pt was diagnosed with (PTSD), Unspecified bipolar and Mild neurocognitive disorder & failure to thrive as he had stopped eating. Pt had received a covid vaccine (J&J) on 5/5/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and length of time between date of vaccines and date of death.
very very sick; no appetite; achy; very fatigued; arm unbelievably sore (she could not turn in bed, even the sheet touching it was painful); fever; shaking chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very very sick), DECREASED APPETITE (no appetite), MYALGIA (achy), FATIGUE (very fatigued) and INJECTION SITE PAIN (arm unbelievably sore (she could not turn in bed, even the sheet touching it was painful)) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced ILLNESS (very very sick), DECREASED APPETITE (no appetite), MYALGIA (achy), FATIGUE (very fatigued), INJECTION SITE PAIN (arm unbelievably sore (she could not turn in bed, even the sheet touching it was painful)), PYREXIA (fever) and CHILLS (shaking chills). On 08-Mar-2021, ILLNESS (very very sick), DECREASED APPETITE (no appetite), MYALGIA (achy), FATIGUE (very fatigued), INJECTION SITE PAIN (arm unbelievably sore (she could not turn in bed, even the sheet touching it was painful)), PYREXIA (fever) and CHILLS (shaking chills) had resolved.            No information regarding corrective treatment was reported by the patient.    Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: NNI
Case number PHEH2014US003964 is an initial spontaneous report received from a pharmacist on 01 Apr 2014. This report refers to a 14 year old female patient. It was reported that her previous vaccinations (unspecified) were well tolerated. On 08 Jan 2014, she was accidentally vaccinated with FLUCELVAX (batch number: 004011A) at a dose of 0.5 ml intramuscularly into left deltoid. No adverse event occurred tot he patient following this medication error (inappropriate age of vaccine administration). Follow up report received from the pharmacist on 01 Apr 2014: Updated vaccination history (previous vaccines well tolerated), vaccine batch number and vaccination site (into left deltoid). Following an internal review on 18 Aug 2014, a significant correction was done for the information received on 01 Apr 2014: BPI labeling of the event "Inappropriate age at vaccine administration" changed from listed to unlisted and added second indication as "drug used in unapproved population.
Arm sore a few days after injection, went away, about one week later, woke up with arm red, swollen painful at inhections site and surrounding area
This spontaneous report as received from a pharmacy student to a 66 year old male patient. ON 20-JUN-2014, the patient was vaccinated with a first 0.5 ml dose of PNEUMOVAX23 (lot # reported as K007821, exp 06-JUN-205) IM in the left arm and on 26-AUG-2014, was inadvertently vaccinated with a second 0.5 ml dose of PNEUMOVAX23 (lot # not reported) IM in the left arm. No adverse effects were reported. Additional information is not expected because the reporter did not want the physician to be contacted.
He is getting little bit nauseous; This is a spontaneous report from a non-contactable consumer (patient's parent). A 15-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Jun2021 (Lot number and expiration date was not reported) as dose 1, single for COVID-19 immunization at the age of 15-year-old. The patient medical history and concomitant medications were not reported. The reporter wanted to know if it was possible to get the vaccine one day other than 21 days and getting exactly on 20 days instead of 21 days. The patient experienced little bit nauseous, it was not major on an unspecified date in Jun2021. No treatment was received for the event. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Janssen COVID-19 Vaccine EAU Had headache starting the day of the shot, continuing into 2nd day. Woke up next morning with headache, low-grade fever (99), body aches, nausea, tiredness, foggy brain and painful arm. Only treatment was taking 1 gram of Tylenol at 10 pm the night of the shot to help with sleep.
Extreme fatigue, dizziness, light-headedness, back pain, weakness, headache, brain fog, nausea, vertigo, moderate arm pain
LEFT SIDE OF FACE RED; TEMPERATURE OF ALMOST 100; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced left side of face red, and temperature of almost 100. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) Almost 100 degree C. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the left side of face red and temperature of almost 100 was not reported. This report was non-serious.
ACUTE NON ST ELEVATION MI HYPOTENSION ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE 3/10/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
This spontaneous report as received from a medical assistant refers to a 15 month old patient of unknown gender. The concurrent conditions, drug reactions/allergies and medical history of the patient were not reported. On 07-DEC-2016, the patient was vaccinated with a dose of improperly stored VARIVAX (strength, dose, route of administration, anatomical location, lot number and expiration date were unknown) for prophylaxis, which was stored at 1.1 Celsius degrees (°C) for 27 minutes, 0.7 °C for 19 minutes, 1.1 °C for 36 minutes, 0.7 °C for 29 minutes, 1.3 °C for 17 minutes, 1.1 °C for 20 minutes, 0.9 °C for 26 minutes, 0.7 °C for 31 minutes and 1.2 °C for 24 minutes. There was no previous temperature excursion. Moreover, the temperature excursions were detected by a data logger. No concomitant therapies nor adverse effects were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA007921: US-009507513-1701USA007910: US-009507513-1701USA004148: US-009507513-1701USA003168: Original Case : 1701USA004150 US-009507513-1701USA007912: Original Case : 1701USA007906 US-009507513-1701USA007922: US-009507513-1701USA007881: US-009507513-1701USA007913: US-009507513-1701USA007882: US-009507513-1701USA004150: US-009507513-1701USA007958: US-009507513-1701USA007906: US-009507513-1701USA007895: US-009507513-1701USA007896: US-009507513-1701USA007923: US-009507513-1701USA004152: US-009507513-1701USA007883: US-009507513-1701USA007897: US-009507513-1701USA007905: US-009507513-1701USA007884: US-009507513-1701USA007924: US-009507513-1701USA007925: US-009507513-1701USA007847: US-009507513-1701USA007885: US-009507513-1701USA007908: US-009507513-1701USA007898: US-009507513-1701USA007914: US-009507513-1701USA007915: US-009507513-1701USA007916: US-009507513-1701USA007848: US-009507513-1701USA007849: